Biotech’s 2026 outlook: Six questions for the year aheadnews2026-01-11T13:45:23+00:00January 11th, 2026|Endpoints News|
Endpoints at JPM 2026: What we’ll be talking aboutnews2025-12-19T12:00:27+00:00December 19th, 2025|Endpoints News|
Post-Hoc Live: Endpoints winners and losers list for 2025news2025-12-17T13:48:27+00:00December 17th, 2025|Endpoints News|
Endpoints Livestream: ACIP and the future of vaccinesnews2025-06-26T10:00:32+00:00June 26th, 2025|Endpoints News|
Endpoints Livestream: China is still the top conversation starter at BIOnews2025-06-18T12:51:31+00:00June 18th, 2025|Endpoints News|
Endpoints 11 nominations: Help us find 2025’s best biotech startupsnews2025-06-16T13:56:22+00:00June 16th, 2025|Endpoints News|
Endpoints Livestream: What happens when AI thinks in ways we can’t understand?news2025-06-11T15:32:23+00:00June 11th, 2025|Endpoints News|
Endpoints livestream: RFK Jr. fired the CDC’s vaccine panel, and what happens nextnews2025-06-10T15:08:22+00:00June 10th, 2025|Endpoints News|
Endpoints Livestream: Is the biotech market really as bad as it seems? news2025-05-28T13:52:35+00:00May 28th, 2025|Endpoints News|
How pharma is reacting to ‘Liberation Day’: Endpoints livestreamnews2025-04-29T18:27:36+00:00April 29th, 2025|Endpoints News|
